ERBB2 and gastric cancer: Despite the high level of concordance between IHC and in situ hybridization methods to evaluate HER2 expression in gastric cancer [51], the current recommendations suggest that samples of patients with IHC 2+ should be referred to in situ hybridization techniques [52].